PMC:7405836 / 116679-117076 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T43","span":{"begin":52,"end":60},"obj":"Body_part"},{"id":"T44","span":{"begin":118,"end":126},"obj":"Body_part"}],"attributes":[{"id":"A43","pred":"fma_id","subj":"T43","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A44","pred":"fma_id","subj":"T44","obj":"http://purl.org/sig/ont/fma/fma82751"}],"text":"Producing similar transbodies against intracellular proteins of coronaviruses, such as papain-like proteases (PLpro), cysteine-like protease (3CLpro), or other nsps, which are essential for replication and transcription of the virus, might formulate a practical move forward for a safer and potent passive immunization approach for virus-exposed persons and rendering therapy to infected patients."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T129","span":{"begin":227,"end":232},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T130","span":{"begin":250,"end":251},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T131","span":{"begin":279,"end":280},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T132","span":{"begin":332,"end":337},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Producing similar transbodies against intracellular proteins of coronaviruses, such as papain-like proteases (PLpro), cysteine-like protease (3CLpro), or other nsps, which are essential for replication and transcription of the virus, might formulate a practical move forward for a safer and potent passive immunization approach for virus-exposed persons and rendering therapy to infected patients."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T236","span":{"begin":52,"end":60},"obj":"Chemical"},{"id":"T237","span":{"begin":118,"end":126},"obj":"Chemical"}],"attributes":[{"id":"A236","pred":"chebi_id","subj":"T236","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A237","pred":"chebi_id","subj":"T237","obj":"http://purl.obolibrary.org/obo/CHEBI_15356"}],"text":"Producing similar transbodies against intracellular proteins of coronaviruses, such as papain-like proteases (PLpro), cysteine-like protease (3CLpro), or other nsps, which are essential for replication and transcription of the virus, might formulate a practical move forward for a safer and potent passive immunization approach for virus-exposed persons and rendering therapy to infected patients."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T22","span":{"begin":206,"end":219},"obj":"http://purl.obolibrary.org/obo/GO_0006351"}],"text":"Producing similar transbodies against intracellular proteins of coronaviruses, such as papain-like proteases (PLpro), cysteine-like protease (3CLpro), or other nsps, which are essential for replication and transcription of the virus, might formulate a practical move forward for a safer and potent passive immunization approach for virus-exposed persons and rendering therapy to infected patients."}

{"project":"LitCovid-sentences","denotations":[{"id":"T790","span":{"begin":0,"end":397},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Producing similar transbodies against intracellular proteins of coronaviruses, such as papain-like proteases (PLpro), cysteine-like protease (3CLpro), or other nsps, which are essential for replication and transcription of the virus, might formulate a practical move forward for a safer and potent passive immunization approach for virus-exposed persons and rendering therapy to infected patients."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3179","span":{"begin":64,"end":77},"obj":"Species"},{"id":"3180","span":{"begin":346,"end":353},"obj":"Species"},{"id":"3181","span":{"begin":388,"end":396},"obj":"Species"},{"id":"3185","span":{"begin":379,"end":387},"obj":"Disease"}],"attributes":[{"id":"A3179","pred":"tao:has_database_id","subj":"3179","obj":"Tax:11118"},{"id":"A3180","pred":"tao:has_database_id","subj":"3180","obj":"Tax:9606"},{"id":"A3181","pred":"tao:has_database_id","subj":"3181","obj":"Tax:9606"},{"id":"A3185","pred":"tao:has_database_id","subj":"3185","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Producing similar transbodies against intracellular proteins of coronaviruses, such as papain-like proteases (PLpro), cysteine-like protease (3CLpro), or other nsps, which are essential for replication and transcription of the virus, might formulate a practical move forward for a safer and potent passive immunization approach for virus-exposed persons and rendering therapy to infected patients."}